Q2 2019 Holdings
Filed 2019-08-13 | 17 holdings | $51.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $41.5M | 1,611,329 | 79.9% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $10.3M | 2,708,207 | 19.8% |
| Milestone Pharmaceuticals Inc(MIST) | COM | 59935V107 | $56.1K | 2,066,529 | 0.1% |
| Ra Pharmaceuticals | COM | 74933V108 | $20.2K | 670,350 | 0.0% |
| Kalvista Pharmaceuticals(KALV) | COM | 483497103 | $14.1K | 637,884 | 0.0% |
| Obseva SA | COM | H5861P103 | $13.1K | 1,159,789 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $13.0K | 1,072,348 | 0.0% |
| La Jolla Pharmaceuticals(LJPC) | COM | 503459604 | $11.6K | 1,251,898 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $11.4K | 289,746 | 0.0% |
| Orchard RX Ltd | COM | 68570P101 | $9.5K | 676,252 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $5.2K | 1,258,964 | 0.0% |
| Kiniksa Pharmaceuticals Ltd | COM | G5269C101 | $4.2K | 312,320 | 0.0% |
| Bellerophon Therapeutics(BLPHEUR) | COM | 078771102 | $1.5K | 2,417,227 | 0.0% |
| Kadmon Holdings Inc.(KDMN) | COM | 48283N106 | $870 | 422,141 | 0.0% |
| Constellation Pharmaceuticals(CNST) | COM | 210373106 | $819 | 66,667 | 0.0% |
| Gemphire Therapeutics | COM | 36870A108 | $646 | 798,066 | 0.0% |
| Proteostasis Therapeutics Inc | COM | 74373B109 | $216 | 221,267 | 0.0% |